Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
$8.12 - $10.37 $4,059 - $5,185
-500 Closed
0 $0
Q4 2020

Sep 15, 2021

BUY
$9.3 - $15.19 $4,650 - $7,595
500 New
500 $4,000
Q4 2020

Jan 27, 2021

SELL
$9.3 - $15.19 $4,650 - $7,595
-500 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$8.24 - $30.8 $4,120 - $15,400
500 New
500 $4,000
Q3 2020

Oct 19, 2020

SELL
$8.24 - $30.8 $4,120 - $15,400
-500 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$7.46 - $23.42 $3,730 - $11,710
500 New
500 $4,000
Q2 2020

Jul 22, 2020

SELL
$7.46 - $23.42 $3,730 - $11,710
-500 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$0.91 - $17.81 $455 - $8,905
500 New
500 $4,000
Q1 2020

Apr 28, 2020

SELL
$0.91 - $17.81 $455 - $8,905
-500 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$0.88 - $1.12 $440 - $560
500 New
500 $4,000
Q4 2019

Jan 27, 2020

SELL
$0.88 - $1.12 $440 - $560
-500 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$0.81 - $1.35 $405 - $675
500 New
500 $4,000
Q3 2019

Oct 22, 2019

SELL
$0.81 - $1.35 $405 - $675
-500 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$0.71 - $1.17 $355 - $585
500 New
500 $4,000
Q2 2019

Jul 31, 2019

SELL
$0.71 - $1.17 $355 - $585
-500 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$0.96 - $2.24 $480 - $1,120
500 New
500 $0

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $25M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.